紫元元(08223.HK)擬2497.1萬元收購深圳福田區濱河大道物業
格隆匯12月8日丨紫元元(08223.HK)公吿,於2022年12月8日,買方深圳市瑞恆醫療供應鏈有限公司(為公司全資附屬公司)與賣方深圳市蘇豪投資有限公司訂立物業購買協議,據此,在物業購買協議條款及條件規限下,買方同意購買而賣方同意出售該物業,代價為人民幣2497.1萬元。"該物業"指中國廣東省深圳市福田區濱河大道5001號紫元元大廈2912室、3902室及4002室。
公司為於開曼羣島註冊成立投資控股有限公司。集團主要於中國從事提供醫療器械設備融資租賃服務、母嬰月子產業服務以及醫療器械及耗材貿易業務。集團擬持有該物業作投資用途以賺取租金收入。經考慮該物業位置,集團相信收購事項為集團提供具吸引力物業投資機會,可於日後實現資本增值及穩定租金收入。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.